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Alcoholism is a heritable disease that afflicts about 8% of the adult population. Its development and symptoms, such as craving, loss of control,
physical dependence, and tolerance, have been linked to changes in mesolimbic, mesocortical neurotransmitter systems utilizing biogenic amines,
GABA, and glutamate. Identification of genes predisposing to alcoholism, or to alcohol-related behaviors in animal models, has been elusive
because of variable interactions of multiple genes with relatively small individual effect size and sensitivity of the predisposing genotype to lifestyle
and environmental factors. Here, using near-isogenic advanced animal models with reduced genetic background interactions, we integrate gene
mapping and gene mRNA expression data in segregating and congenic mice and identify glutamate receptor metabotropic 7 (Grm7) as a cis-
regulated gene for alcohol consumption. Traditionally, the mesoaccumbal dopamine reward hypothesis of addiction and the role of the ionotropic
glutamate receptors have been emphasized. Our results lend support to an emerging direction of research on the role of metabotropic glutamate
receptors in alcoholism and drug addiction. These data suggest for the first time that Grm7 is a risk factor for alcohol drinking and a new target in
addiction therapy.
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expression of most of the common diseases, such as high
blood pressure, diabetes, cancer, depression, alcoholism, and
Alzheimer disease. Although from a societal point of view
common diseases are in the focus, in most common diseases
progress in identifying genes has been limited to a small
percentage of individuals with fully penetrant genes of large☆ Microarray gene expression data have been deposited with the GEO
repository under Series Entry GSE7155.
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doi:10.1016/j.ygeno.2007.08.006effect. Therefore, in general, most of the research efforts have
focused on the biological effects of these major genes. The vast
majority of a population with a common disease is character-
ized by a complex phenotype with the involvement of a
network of multiple interacting genes, each with individually
small effect size against a background of variable environ-
mental influences. Despite intensive research efforts, progress
in identifying these minor genes has been slow. In alcoholism,
even in animal models of alcohol-related behaviors [1–5], the
contribution of defined genetic factors seems certain in only
very few cases.
Most of the preclinical gene mapping studies with animal
models have been based on recombinant inbred (RI) or
Mendelian segregating population designs. In RI or Mendelian
designs in each strain or in each individual, respectively, the
691C. Vadasz et al. / Genomics 90 (2007) 690–702genetic background is unique and represents a specific source of
genetic interaction. This interaction between the target gene and
the background may substantially contribute to the total genetic
variance and may limit detection of polygenes with small effect
size reliably. Recently, to reduce genetic background noise, we
developed a different design with 78 near-isogenic inbred strains
of N97% C57BL/6ByJ (B6By) genetic background identity and
mapped six quantitative trait loci (QTLs) for alcohol consump-
tion [6,7]. Given this and the availability of near-isogenic strains
as convenient precursors for rapid development of congenic
strains, we tested different genetic designs to confirm linkage
between alcohol consumption and one of the QTLs, ethyl
alcohol consumption-2 locus (Eac2) mapped to distal Chr. 6, and
used bioinformatic methods to examine the Eac2 region in a
search for the underlying quantitative trait gene (QTG).
Here, we report an integrated genome and transcriptome
analysis of the Eac2 region on Chr. 6, which suggests that a gene
coding for metabotropic glutamate receptor subtype-7 (Grm7) is
a candidate QTG for Eac2.
Results
Alcohol consumption in a congenic strain
Using microsatellite marker-assisted selection and repeated
backcrosses to the alcohol-preferring B6By background strain,
we developed a new congenic strain, B6By.C.6.132.54 (B6By.
C6). This congenic strain carries a BALB/cJ (C) donor chromo-Fig. 1. Alcohol consumption in inbred congenic mice and segregating quasi-congenic
composition in C57BL/6ByJ (background strain, black chromosomes), BALB/cJ (d
donor chromosome segments), and B6By.C6 (B6By.C.6.132.54, a congenic strain d
were the only chromosomes that harbored differential donor segments in C5A3. In a p
was significantly lower than that in the background C57BL/6ByJ (F1,13=6.21, p=0
genotyped reciprocal F2 population derived from respectively alcohol-preferring and
independently derived quasi-congenic strains on the B6By background. C5B3 carries
of C5A3 and B6.C6 (see details under Methods in the supporting information). F2
alcohol than mice with the T:T (BALB/cJ/BALB/cJ) genotype (independent samples
36) is in intron7 of Grm7. G:G has been detected in alcohol-preferring C57BL/6J a
BALB/cJ, BALB/cByJ, DBA/2J, and A/J (http://www.jax.org/phenome).some segment on Chr. 6 with proximal and distal background
markers D6Mit275 (25.5 cM, 51.1 Mb, from UniSTS annota-
tion of NCBI build 36) and D6Mit134 (57.5 cM, 125.3 Mb),
respectively. The congenic strain in a two-bottle free-choice
alcohol preference test demonstrated significantly lower con-
sumption of 12% (v/v) alcohol in comparison to its background
partner B6By, confirming a significant decreasing effect of the
genetic factor(s) residing on the donor segment (Fig. 1A). In an
additional independent test, using a two-bottle choice para-
digm with intermittent access to alcohol, we found that con-
sumption of 12% alcohol was significantly higher among B6By
males (12.70±1.03, n=13) in comparison with B6By.C6 males
[8.37±0.96 (g/kg/day, mean±SE), n=19, average of four 3-day
trials, t30=3.00, p=0.005, two-tailed].
To test the hypothesis that other undetected donor chromosome
segments are responsible for this effect, a genome scan with a
mouse single-nucleotide polymorphism (SNP) panel of 402
markers was carried out. No additional donor segments were
detected (Fig. S1). Because the genome scan showed flanking
background markers at 75.9 Mb (rs4226008; NCBI mouse build
36/dbSNP build 126) and 122.3 Mb (rs3023093), and limiting
donor markers at 81.9 (rs4226024) and at 91.8 Mb (rs3712161),
we concluded the segment size must be between 9.9 and 46.4Mb.
Exclusion of identical-by-descent regions
For narrowing the set of candidate genes, first, the donor
segment in the B6By.C6 congenic strain was subjected topopulation. (A) Alcohol consumption (g/kg/day; mean±1 SE) and chromosome
onor strain, white chromosomes), C5A3 (a quasi-congenic RQI strain carrying
erived from C5A3). Only chromosomes 1, 5, 6, and 7 are shown because these
replanned comparison, alcohol consumption among the congenic B6By.C6 mice
.028). (B) SNP allelic effects on oral alcohol self-administration in a selectively
alcohol-nonpreferring inbred strains I5B25A and C5B3. I5B25A and C5B3 are
a BALB/cJ-derived chromosome segment that overlaps with the Chr. 6 segments
individuals with the G:G (B6By/B6By) genotype consumed significantly more
t test, t27=2.1, p=0.048). SNP rs3723352 (Chr. 6: 111.318602 Mb; NCBI build
nd C57BL/6ByJ strains, while T:T has been detected in alcohol-nonpreferring
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DNA resequencing and SNP discovery efforts overseen by the
National Institute of Environmental Health Sciences (NIEHS),
which recently made available 8.3 million SNPs among the
genomes of 15 diverse inbred strains (http://www.niehs.nih.
gov/oc/news/snp2.htm). Bioinformatic analysis of the Chr. 6
segment between 75.9 and 122.3 Mb indicated 404 known
genes. The mapping and congenic data suggest that one or more
DNA differences in the region between B6By and C are the
ultimate cause of the QTLs. Because most inbred laboratory
mouse strains [8], including the progenitor strains, shared a
common ancestor [9], some regions of their genome will be
largely identical by descent (IBD). IBD regions, which are not
considered strong positional candidates [10], can be identified
by a low frequency of SNPs between two inbred strains. Can-
didate genes are more likely to fall in non-IBD regions; there-
fore positional cloning should focus on subregions where the
progenitors differ. We analyzed the SNP distribution histogram
between B6 and BALB/cByJ (CBy) on Chr. 6 between 75.9 and
122.7 Mb (http://www.jax.org/phenome/snp.html). Identifying
11 IBD regions (SNP frequency b20/0.1 Mb: 77.4–78.1, 78.6–
80.2, 83.8–85.6, 86.2–86.8, 95.6–96.6, 98.6–100.9, 102.4–
104.1, 107.4–107.6, 112.4–118.8, 121.8–122.3 Mb), we could
reduce the number of candidate genes on the maximum segment
length (46.4 Mb) to 212 genes. Application of this criterion
filtered out, for example, Slc6a1 (114.85 Mb; neurotransmitter
transporter, GABA, member 1), an otherwise likely candidate
(Fig. 2).
Structural polymorphism
The Chr. 6 interval between 75.9 and 122.7 Mb was searched
for coding-nonsynonymous SNPs (CNs) between B6, CBy, and
C. Genes (AW146020, Htra2, Dguok, Frmd4b, Pdzrn3, Cntn6,Fig. 2. Narrowing of a set of candidate genes. Identification of IBD regions by analy
were identified by low frequency of SNPs between B6 and C (SNP frequency b20/0.1
available for both C57BL/6J and BALB/cByJ. Red bars represent the number of SN
representative region, near the end of the donor segment in the congenic B6.C6 str
114.246521 Mb) was filtered out.Setmar, EG640530) harboring a total of nine CNs fell in a non-
IBD region, while two CNs (one each in Ppp4r2 andMug2) fell
in IBD regions, though near the borders. These results are con-
sistent with the expected functionality of the IBD filter. Effects
of these CNs on protein function, interaction, and thermodyna-
mic stability are not known.
Analysis of Gene Ontology (GO) classifications (which was
not available for Ppp4r2 or predicted gene EG640530) suggest-
ed that the expressed sequence AW146020 has DNA binding
activity and is involved in the regulation of DNA-dependent
transcription; Htra2, serine peptidase 2, is involved in the
regulation of body size, adult locomotor/walking behavior and
neuron development, mitochondrion organization and biogen-
esis, apoptosis, and proteolysis;Dguok, deoxyguanosine kinase,
is involved in a nucleic acidmetabolic process and protein amino
acid phosphorylation; and Frmd4b, FERM domain-containing
4B, is in the cytoplasm and in a membrane location. GO infer-
ences based on these domains also imply that the gene product
has cytoskeletal protein binding activity. Pdzrn3, PDZ domain-
containing RING finger 3, has zinc ion binding activity and is
involved in an intracellular signaling cascade, the gene product
has protein binding activity; Cntn6, contactin 6, has ATP bind-
ing activity andATPase activity andGPI anchor binding activity,
coupled to transmembrane movement of substances activity, and
is involved in protein binding activity, cell adhesion, and the
Notch signaling pathway; Setmar, SET domain and mariner
transposase fusion gene, has methyltransferase activity and is
involved in chromatin modification; Mug2, murinoglobulin 2,
has transporter activity and receptor activity and is involved in
transport, has wide-spectrum protease inhibitor activity, and has
serine-type endopeptidase inhibitor activity. Although the
available information is insufficient to exclude these genes, the
known functions do not suggest obvious plausible links to
alcohol drinking preference or addiction.sis of SNP distribution histograms (http://www.jax.org/phenome). IBD regions
Mb). Gray bars represent the number of SNP locations for which allele data were
P locations at which alleles for C57BL/6J and BALB/cByJ are different. This
ain, illustrates how Slc6a1 (a likely candidate for alcohol-related behaviors, at
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In several recent studies it has been recommended that a set
of candidate genes can be narrowed by requiring the gene to be
expressed, to be correlated with the phenotype of interest, and to
have cis-regulated expression [11–17]. To filter the remaining
212 genes for expression and genotype-dependent transcript
abundance we analyzed gene expression data obtained from the
CXB RI strain set. Gene expression QTL mapping of the CXB
RI strains is highly informative for our study because the pro-
genitors of the RI and RQI strains are identical (C57BL/6By) or
closely related (BALB/cBy vs BALB/cJ). Interval QTL map-
ping of mRNA abundance of the 212 genes was implemented
using the Hippocampus Consortium M430v2 CXB (Dec05)
Robust Multiarray Average (RMA) database (http://www.
genenetwork.org/public/WebQTL.py). The lod (logarithm of
the odds to the base 10) scores for expression of the 212 genes
were tested for genome-wide significance (1000 permutations
[18]). The criterion of cis-regulation was the identification of a
single peak of the transcript abundance QTL with genome-wide
significance (pb0.05) and a peak position identical or near to
the genomic location of the gene. Only 7 genes had genome-
wide statistically significant lod scores: Lrrtm4, Sema4f, Aak1,
Nfu1 (aka Hirip5), Chchd4, Grm7, and Cecr5 (Table 1). Peaks
of the transcript abundance QTLs for these genes fell into bins
that included their genomic locations, indicating the possibility
of cis-regulation of these genes. In the CXB hippocampal data
set the B6 alleles increased gene expression for Lrrtm4, Sema4f,
Aak1, Nfu1 (aka Hirip5), and Chchd4, while for Grm7 and
Cecr5 the C alleles increased expression (Table 1).
Polymorphism in cis-regulated genes
Focusing on the seven candidate genes, in a search for
DNA polymorphisms in NCBI dbSNP build 126 (http://www.
informatics.jax.org) between C57BL/6J (B6; reference strain)
and BALB/cByJ, BALB/cJ, or BALB/c within coordinates of
the candidates we found 67 matching SNPs for Lrrtm4, 0 for
Sema4f, 47 for Aak1 (6 mRNA-UTR, 1 coding-synonymous,
40 intron), 11 for Nfu1 (6 mRNA-UTR, 5 intron), 14 for Chchd4Table 1
Cis-regulated genes in donor chromosome segment
Chr. cM Genome coordinates,
NCBI build 36 (strand)
Symbol, name
6 Syntenic 79948557–80738698 (+) Lrrtm4, leucine-rich repea
6 35 82877544–82905386 (−) Sema4f, sema domain, im
TM domain, and short cy
6 35.5 86815474–86957498 (+) Aak1, AP2-associated kin
6 86975523–86994094 (+) Nfu1, NFU1 iron–sulfur c
(Saccharomyces cerevisia
6 Syntenic 91429780–91438927 (−) Chchd4, coiled-coil–helix
domain-containing 4
6 Syntenic 110611375–111533007 (+) Grm7, glutamate receptor
6 54 120475114–120496924 (−) Cecr5, cat eye syndrome
candidate 5 homolog (hum
a Affymetrix oligonucleotide microarray, Mouse Genome 430 2.0, Hippocampus
* pb0.05, genome-wide significance test (1000 permutations).(2 mRNA-UTR and 12 intron), 218 for Grm7 (intron), and 0 for
Cecr5.
Gene expression differences in congenic and background
strains
It has been suggested that by comparing gene expression in
strains with well-defined small genomic differences cis-
regulation of expression can be detected [7,19,20]. To test the
expected congenic vs background differences in expression, in a
microarray gene expression experiment we compared the seven
cis-acting genes for differences in relative brain mRNA abun-
dance between the background B6By, the congenic B6By.C6,
and the donor C. As shown in Table 2, expression of Lrrtm4,
Sema4f, Aak1, and Cecr5 was not significantly different among
the strains, while significant genetic variation was detected for
three genes: Nfu1, Chchd4, and Grm7 (p=0.000–0.036; one-
way ANOVA, SPSS version 13). For Nfu1, Chchd4, and Grm7
significantly different expression was detected between the
background B6By and the congenic B6By.C6 after correction
for multiple comparisons (Table 2). The direction of the allelic
effects for whole brain transcript abundance between the pro-
genitor and the congenic strains agreed with the results of the
Hippocampus Consortium M430v2 CXB (Dec05) RMA data-
base analysis for most of the candidate genes.
Multistrain analysis
To see if any of these genes showed genotype–alcohol con-
sumption correlation across commercially available common
inbred strains with publicly accessible data we estimated the
correlation between genotypes of the four significant (Nfu1,
Chchd4, andGrm7) or near-significant (Aak1) SNPs and alcohol
consumption in strains B6, AKR/J, C, A/J, DBA/2J, 129/SvJ,
and C3H/J using previously published alcohol consumption data
[21–23]. We found that alcohol consumption was highly cor-
related with genotypes of Nfu1 (rs30605208, n=6, r=−0.96,
p=0.001) and Aak1 (rs30912462, n=4, r=−0.95, p=0.02).
Relatively high correlation was found for Grm7 (rs305571150,
n=8, r=−0.57), which did not quite reach the p=0.05 level ofProbe set a Lod score B6 allele
effect
t transmembrane neuronal 4 1455937_at 5.5* Increase
munoglobulin domain,
toplasmic domain
1419328_at 4.3* Increase
ase 1 1435038_s_at 7.5* Increase
luster scaffold homolog
e), aka Hirip5
1418229_s_at 6.6* Increase
–coiled-coil–helix 1417233_at 11.5* Increase
, metabotropic 7 1459532_at 6* Decrease
chromosome region,
an)
1424816_at 4.3* Decrease
Consortium M430v2 CXB RMA data set.
Table 2
Cerebral gene expression differences between congenic and progenitor strains
Gene on donor
segment
Probe set ID Strain Mean Standard
deviation
Standard
error
df F Significancea Tukey
HSDb
Lrrtm4 1455937_at B6By 11.41 1.13 0.65 2 1.91 0.229 0.313
BALB/cJ 9.76 0.63 0.36
B6By.C6 9.9 1.5 0.87
Sema4f 1419328_at B6By 52.3 3.15 1.82 2 3.05 0.122 0.106
BALB/cJ 48.08 1.98 1.14
B6By.C6 44.12 5.97 3.44
Aak1 1435038_s_at B6By 357.46 55.46 32.02 2 3.25 0.111 0.24
BALB/cJ 272 22.59 13.04
B6By.C6 293.84 43.37 25.04
Nfu1 1418229_s_at B6By 138.17 5.47 3.16 2 10.09 0.012 0.036
BALB/cJ 98.09 12.88 7.44
B6By.C6 106.83 14.15 8.17
Chchd4 1417233_at B6By 171.16 21.76 12.56 2 39.62 0 0.001
BALB/cJ 76.72 6.73 3.89
B6By.C6 84.33 10.33 5.96
Grm7 1459532_at B6By 6.74 0.7 0.4 2 6.11 0.036 0.049
BALB/cJ 9.34 1.52 0.88
B6By.C6 9.46 0.83 0.48
Cecr5 1424816_at B6By 29.81 1.81 1.04 2 1.08 0.398 0.848
BALB/cJ 31.29 1.15 0.66
B6By.C6 28.91 2.74 1.58
Affymetrix oligonucleotide microarray, Mouse Genome 430 2.0. Vadasz–Saito Cerebral Gene Expression database, GEO repository series entry GSE7155.
a Between-group difference, one-way ANOVA of RMA normalized data.
b Post hoc test for B6By vs B6By.C6.
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(rs30014728, n=6, r=−0.27, p=0.3). Evaluating the results of
multistrain analysis, we have to keep in mind its limitations in
support of QTG candidacy. In our view, it can be only tenta-
tively useful in either supporting or refuting QTG candidacy of
a gene.
GO annotation summary of the candidate genes indicated
that while the biological process in which Nfu1 is involved is
not known, it may have a housekeeping function; Aak1 may be
involved in protein amino acid phosphorylation and endocy-
tosis; Chchd4 appears to be involved in mitochondrial protein
transport; and Grm7 has been intensively characterized as a G-
protein-coupled receptor protein that is involved in synaptic
transmission, behavioral fear response, sensory perception, and
stress (Table S3).
Promoter analysis
Analysis of the genotype–alcohol consumption correlation
and the GO annotation summaries left Grm7 as the primary
candidate for testing the hypothesis that genetic variation in
expression is associated with a mutation in a transcription factor
binding site (TFBS). Analysis of Grm7 by the PromoterInspec-
tor program predicted 13 promoters and two regulatory regions
(http://www.genomatix.de). PromoterInspector is a program
that predicts eukaryotic Pol II promoter regions with about 85%
specificity in mammalian genomic sequences. Accordingly, one
may expect PromoterInspector to find good matches but not all
promoters.
Comparing the positions of the 218 SNPs detected in Grm7
we found 1 SNP (rs30557150) in a promoter region (fifth pro-moter, 110,819,264–110,819,864 bp, Fig. 3). MatInspector, a
program that detects TFBSs in nucleotide sequences using a
large library of weight matrices, identified a TFBS above a good
match threshold: V$SORY/SOX5.01 (matrix similarity=0.987;
core similarity=1.0) (http://www.genomatix.de). The TFBS
was lost due to SNP rs30557150 (C/T) in the rs30557150_C
allele of Grm7, which is consistent with the observation that
C57BL/6J carrying the rs30557150_C allele showed lower
transcript abundance of Grm7 than strains with the
rs30557150_T allele (Fig. 3). However, experimental evidence
is required to provide sufficient proof for the involvement of
this TFBS in transcriptional function. In a test of different
microarray gene expression probe sets in WebQTL (http://www.
genenetwork.org), results of eQTL mapping suggested cis-
regulation for Sox5 in the mouse hippocampus in both BXD and
CXB RI strain sets. Whole genome mapping with 1000
permutation test yielded LOD=31.56 with peak location
between 144.01 and 144.82 Mb in the BXD population
(database: Hippocampus Consortium M430v2 (Jun06) PDNN;
Trait ID: 1446461_at); however, no significant peak was found
for another probe set (1432189_a_at). No significant peak was
found for 1446461_at in the Hippocampus ConsortiumM430v2
CXB (Dec05) PDNN database. Whole genome mapping with
1000 permutation test yielded LOD=3.0 for probe set
1432189_a_at, but no significant peak was found for probe
set 1446461_at, in the Hippocampus Consortium M430v2 CXB
(Dec05) RMA database. We found 362 SNPs in Sox5 in a
comparison of B6, DBA/2J, and BALB/cBy, including an
mRNA-UTR insertion (rs6151967, http://www.informatics.jax.
org), which is consistent with the hypothesis that probe set
differences may reflect heterogeneity.
Fig. 3. Reference flanking sequence of SNP rs30557150. Cis-regulated Grm7 is polymorphic (C/T) in a regulatory region among mouse strains. rs30557150 (Chr. 6:
110,819,852 inGrm7) is a putative promoter SNP. Strains with higher transcript abundance (BALB/cJ, BALB/cByJ, DBA/2J, A/J; Hippocampus ConsortiumM430v2
CXB (Dec05) RMA data set at http://www.genenetwork.org; ProbeSetID=1459532) carry the “T” allele, while strains with lower transcript abundance (C57BL/6ByJ,
C57BL/6J, AKR/J, NOD/LtJ; Hippocampus Consortium M430v2 BXD (Dec05) PDNN; ProbeSetID=1459532) carry the “C” allele.
695C. Vadasz et al. / Genomics 90 (2007) 690–702No significant “genetic” (between-strain) correlation was
found between hippocampal expression of Sox5 (1432189_a_at)
and of Grm7 (1459532_at) in the CXB population (Pearson’s
correlation: r=0.498, n=15, p=0.059, two-tailed) or between
hippocampal expression of Sox5 (1446461_at) and Grm7
(1459532_at) in the BXD population (Pearson’s correlation:
r=−0.178, n=69, p=0.147, two-tailed).
Confirmatory analysis of cis-regulation of Grm7
Although the hippocampus has been implicated in
addiction [24] and alcohol consumption [4], traditionally, it
has not been considered as a region critically involved in
alcohol preference and dependence. Therefore, we performed
additional expression QTL mapping on two striatal data-
bases created for BXD and B6D2F2 populations (see
Materials and methods). To test the between-strain general-
izability of the CXB hippocampal gene expression results,
an additional BXD hippocampal data set was analyzed. As
shown in Fig. 4, the results of the confirmatory analyses
provided strong support for cis-regulation of Grm7 in both
brain regions.
Confirmatory analysis of linkage in reciprocal F2 populations
We used an alternative genetic design for testing the asso-
ciation between Grm7 and alcohol consumption. Reciprocal F2
populations were created by crossing F1 hybrids of alcohol-preferring (I5B25A) and alcohol-nonpreferring (C5B3) quasi-
congenic RQI strains, which are on the same genetic back-
ground (both strains carry N97% B6 genome [6]). F2 mice were
selectively (N1 SD above or below mean alcohol consumption)
genotyped for a SNP marker (rs3723352, G/T) that resides in
intron 7 of Grm7 at Chr. 6: 111,318,602 (NCBI build 36). Be-
cause consumption of 12% (v/v) alcohol (g/kg/day, average of
four 3-day trials) was not significantly different between the
selectively genotyped reciprocal F2 groups (F1,56=0.73, p=
0.79), data were combined. Comparison of the B6By/B6By (G:
G) and BALB/cJ/BALB/cJ (T:T) homozygotes indicated that
individuals with the B6By/B6By genotype consumed signifi-
cantly more alcohol (independent samples t test, t27=2.1, p=
0.048; Fig. 1B). These results were consistent with data
obtained from RQI QTL mapping [7], detection of T:T
genotypes in other inbred strains (e.g., CByJ, 129/SvJ, DBA/
2J) known to show low alcohol consumption, and results of the
alcohol preference tests with B6By.C6 congenic animals (Fig.
1A). Importantly, the quasi-congenic F2 experiments also
provided supportive evidence for the exclusion of competing
candidate genes Nfu1, Aak1, and Chchd4, because the alcohol-
nonpreferring C5B3 quasi-congenic RQI strain did not carry the
BALB/cJ-type alleles of Nfu1, Aak1, and Chchd4. To create the
F2 on an ∼97% homogeneous background, RQI strain C5B3
was chosen for the cross because it carries a BALB/cJ-
derived Chr. 6 segment (with flanking background markers
D6Mit230 at 98.97 Mb and D6Mit258 at 137.07 Mb), which
partially overlaps the BALB/cJ-derived Chr. 6 segment in the
Fig. 4. Expression QTL mapping in four data sets. QTL mapping of mRNA abundance of candidate genes was carried out using WebQTL (http://www.genenetwork.org). Grm7 (ProbeSetID=1459532_at) had genome-
wide statistically significant lod scores with peaks at (or near) its genomic location in the following data sets: CXB Hippocampus (LOD=6.0), BXD Striatum (LOD=7.3), B6D2F2 Striatum (LOD=21.1), BXD
Hippocampus (LOD=20.5). For data set details see Materials and methods.
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697C. Vadasz et al. / Genomics 90 (2007) 690–702congenic B6By.C6 (75.9–122.3 Mb, Fig. 1A). In the
alcohol-preferring I5B25A quasi-congenic strain, BALB/cJ-
derived alleles were detected only on Chrs. 8 and 13. In
C5B3, the whole BALB/cJ-derived Chr. 6 segment was
positioned distal from the genomic positions of AW146020,
Htra2, Dguok, and Frmd4b (genes identified with structural
polymorphism) and Nfu1, Aak1, and Chchd4 (genes
identified as cis-regulated).
Discussion
In our recent studies composite interval mapping identified
several significant linkages to ethyl alcohol consumption on
mouse Chr. 6 and indicated that the RQI donor block region for
Eac2 spans 33.5–48.2 cM [7]. Eila2 (36.5 cM), Etlm3 (30 cM),
Rear1 (36.5 cM), Bits2 (37 cM), and Taste5 (48 cM) are
previously identified behavior and preference QTLs mapping
to this interval. Interestingly, despite intensive efforts, mapping
studies on QTLs for murine alcohol preference drinking
behavior using the most popular BXD recombinant inbred
strains and various genetic preparations derived from the
progenitor strains failed to identify QTLs in this chromosome
region [1]. Reasons for the failure may include, but are not
limited to, the following: different mapping strategy (our quasi-
congenic RQI strains have ∼97% “background homogeneity,”
significantly reducing epistatic interaction variation, i.e.,
genetic background noise, which can mask target allele signals
[25–28]), different laboratories with differences in testing
procedures [29,30], and differences between DBA/2J and
BALB/cJ in genomic architecture (different gene dispersion
patterns+different mode of gene action in each strain resulting
in various increaser–decreaser linkages with different tightness,
different interactions with the B6 genes and environmental
modifiers, etc.). It is possible that the task of mapping and
sequencing true polygenes has been underestimated [31]. For
example, two polygenes with small effect size exhibiting
antagonistic epistasis may be mapped to a single small QTL
region (b1 cM), such that their phenotypic effect depends on
the genetic background [32]. If similar complications are
typical for behavioral traits, it may explain the inability to
predict results of new crosses based on RI or classical
intercross mapping results (cf. [33]).
In this study we integrated genetic, transcriptome, and bio-
informatic approaches to identify quantitative trait genes for a
behavioral phenotype, oral alcohol self-administration. The
results suggest that Grm7, which encodes the group III meta-
botropic glutamate receptor 7 (mGluR7), modulates alcohol
drinking: Mice carrying the genotype that predisposes for lower
expression of Grm7 in the brain consume more alcohol in a
preference drinking behavioral paradigm. Molecular, cellular,
and biological functions of Grm7/mGluR7 strongly support this
suggestion.
Studies on human mGluR7 mRNA splicing variants have so
far revealed five isoforms [34,35] and suggest that structural
and functional diversity of this receptor is achieved by
alternative exon usage affecting the immediate carboxy-
terminus. This region interacts with defined proteins, such asPICK [36], α-tubulin [37], and calmodulin [38], thus mediating
various receptor functions such as intracellular signal transduc-
tion, axonal targeting, and synaptic clustering. Most variants
are expressed in brain and retina, while human isoforms
GRM7_v3 and GRM7_v4 are expressed in nonneuronal tissues
[35]. In rats, two splice variants (mGluR7a and mGluR7b)
have been reported, which are defined by different C-termini
[39]. Immunohistochemical studies using antibodies raised
against the C-termini of rat mGluR7a and human mGluR7b
showed similar, but not identical, distributions in the brains of
rats and mice [40]. Alternative splicing, in addition to probe
ambiguity (targeting multiple genes), heterogeneity (targeting
different transcript variants from one gene), and other factors,
may explain our observation that only one of the four
Affymetrix Mouse 430 2.0 probe sets for Grm7 could detect
cis-regulation [41].
Sox5 (SRY-box containing gene 5) is a novel SRY-related
transcription factor [42]. The genomic location of this TF (Chr.
6, 69.5 cM, 143,790,051–144,166,639 bp) is just 33.178 Mb
distal from that of Grm7. One of its known functions is related
to cell fate commitment and cartilage development [43]; how-
ever, its functions in the brain or interactions with Grm7 are not
known, and its cis-regulated expression did not show a cor-
relation with that of Grm7 in CXB or BXD strain sets (see
Results). Thus, the hypothesis that Sox5 may play a role as a
transcription factor in the regulation of expression of Grm7 in
the brain needs further support.
mGluR7 is a presynaptic autoreceptor, or heteroreceptor, in
nonglutamatergic axon terminals, with an inhibitory action on
the release of various neurotransmitters such as glutamate,
GABA, and monoamines [44]. There is a considerable overlap
between the neuroanatomical distribution of mGluR7 and me-
solimbic brain regions, suggesting that this receptor has a parti-
cularly crucial role in processing information, which can modu-
late neurotransmitter release in pathways involved in addiction
and reinstatement. High representation of mGluR7 was ob-
served in the amygdala [45], the periventricular zone of the
hypothalamus, and the olfactory circuitry [46]. Simonyi et al.
found the highest levels of mGluR7 expression in the dentate
gyrus, CA1, CA3, and piriform cortex [47]. Recently deposited
microarray data indicated relatively high Grm7 expression in
amygdala, hippocampus, and cerebellum in various mouse
strains, including B6 and CByJ [48].
Genetic ablation of mGluR7 in mice provided further
supportive data. Grm7 knockouts showed altered amygdala-
dependent conditioned fear and aversion responses and reduced
anxiety-related behaviors, suggesting a role for mGluR7 in
the modulation of stress-related behaviors [49,50]. Indeed, a
new specific agonist of mGluR7 activated the hypothalamic–
pituitary–adrenal (HPA) axis and dramatically increased stress
hormone levels [51]. A possible glutamatergic mechanism
underlying the activation of the HPA axis, which may have
relevance to alcohol drinking, involves disinhibition of cortico-
tropin-releasing factor (CRF)-containing paraventricular nuc-
leus (PVN) neurons, which leads to increased ACTH and cor-
ticosterone levels: Activation of the presynaptic inhibitory
mGluR7 receptor can decrease L-glutamate release from the
698 C. Vadasz et al. / Genomics 90 (2007) 690–702hippocampal–hypothalamic pathway, decreasing the excitatory
tone on GABAergic neurons, or agonists may activate mGluR7
heteroreceptors directly, decreasing the inhibitory tone on PVN
neurons [50,52,53]. In stress-induced alcohol drinking and re-
lapse behavior both the glutamate system and the corticotropin-
releasing hormone system have been implicated [44,54,55]. The
proposed role for the amygdala in the relationship among stress,
CRF, and alcohol abuse [56], and the role of Grm7 in stress, is
consistent with a link between the genetic variation in Grm7
and predisposition to alcohol drinking. Our present observation
of increased expression of Grm7 in BALB/cJ and earlier reports
proposing the BALB/cJ strain as an animal model for patholo-
gical anxiety [57,58], characterized by increased “freezing” and
emotionality in open-field test [59–61] and by elevated stress-
induced corticosterone and emotionality [62], are also consis-
tent with the anxiolytic effects of targeted disruption of Grm7
[49].
Although the mesolimbic dopamine reward hypothesis of
addiction has been traditionally important in psychostimulant
use and abuse [63–65], there is emerging evidence that gluta-
mate systems play a critically important role in reinforcement
and addiction [66]. It has been shown that glutamatergic inner-
vation of the VTA and the nucleus accumbens regulates loco-
motor activity [67]. mGluR7 may be implicated in regulation of
motor activity, because administration of group III mGlu
receptor agonist L-AP4 attenuates acute amphetamine [68]- and
cocaine [69]-stimulated locomotor activity. In studies on the
link between alcohol effects and the glutamatergic neurotrans-
mission the emphasis has been on the role of the ionotropic
glutamate receptors; however, research on the role of metabo-
tropic glutamate receptors in alcohol use is gaining impetus
[70]. It has been shown that chronic exposure to alcohol reduced
mGluR1 mRNA levels in cerebellar Purkinje cells in mice [71].
In rats, chronic exposure to Lieber–DeCarli liquid diet with
alcohol (5% w/v) decreased mRNA levels of mGluR3 and
mGluR5 in dentate gyrus, while levels of mGluR1, mGluR5,
and mGluR7 were decreased in the CA3 area of the hippo-
campus [72]. Such adaptations in mGluR7 expression to long-
term exposure to alcohol are also expected in excessive alcohol
self-administration, and reduced mGluR7 expression may
become a causative factor in excessive drinking, which is con-
sistent with our results.
Use of pharmacological agents indicates that the mGluR5
antagonist MPEP decreases relapse to alcohol self-administra-
tion [70,73,74], blocks the discriminative stimulus effects of
alcohol [75], and attenuates latent inhibition in conditioned taste
aversion [76]. Based on the supporting psychopharmacological
data and its high expression in the nucleus accumbens, cortex,
and hippocampus [77], it was proposed that mGluR5 receptors
might specifically regulate ethanol reinforcement [70]. Recent
experiments indicated that the novel mGluR7-specific agonist
AMN082 inhibited cocaine self-administration [78], and
reverse dialysis studies demonstrated that group III agonist L-
AP4, possibly acting on mGluR7, decreased in vivo extra-
cellular glutamate in the nucleus accumbens by inhibiting
nonvesicular glutamate release, and group III antagonist MSOP
increased extracellular accumbal glutamate [79]. Thus, it ap-pears that the postsynaptic mGluR5 receptors need to be blocked,
while the presynaptic mGluR7 receptors need to be activated, for
inhibition of psychostimulant self-administration. Significant
downregulation of Grm7 has recently been reported in mice
lacking the subunit α1 of the GABA-A receptor (Gabra1) [80].
Because GABRA1 is associated with alcohol dependence [81],
there is the possibility of signaling and genetic interaction bet-
ween the two receptors.
The source of tissue in our expression QTL mapping may be
a source of concern, because the hippocampus is not generally
considered as tightly linked to addiction. Thus, the question
may be raised “Are hippocampal expression data relevant to
alcohol drinking?” Although debate continues over the biolo-
gical mechanisms of reward and addiction, hippocampal ex-
pression data are relevant to alcohol drinking because the hip-
pocampus is an important part of the limbic circuitry, a neural
substrate of reinforcement and drug addiction. One of the
functions of the limbic cortical–ventral striatopallidal thalamo-
cortical loop circuitry is processing of contextual information by
the hippocampus [82]. For example, dorsal hippocampus inac-
tivation abolishes contextual, but fails to alter explicit condi-
tioned stimulus- or cocaine-induced, reinstatement of cocaine-
seeking behavior [83]. It appears that the amygdala mediates
conditioning to discrete conditioned stimuli, and the hippo-
campus mediates contextual or spatial stimuli and may underlie
the motivational impact of contextual stimuli on drug seeking
[82].
Using progenitor strain-derived mapping population and
additional expression data derived from amygdala, ventral and
dorsal striatum, and prefrontal cortex would have been ideal;
however, currently such databases are not available. The most
relevant and available expression mapping database is derived
from hippocampal tissue of CXB RI mice. The progenitor
strains in this RI set are BALB/cByJ and C57BL/6ByJ; thus one
of the progenitors (BALB/cByJ) is a subline of BALB/cJ, the
strain that was used as progenitor in our experiments. As of July
2007, the SNP-based genetic similarity between BALB/cByJ
and BALB/cJ cannot be assessed very reliably because the
density of SNP coverage differs. BALB/cByJ has 7,675,370
SNPs, BALB/cJ has 86,221 SNPs (http://phenome.jax.org).
Selecting the entire genome, and requiring that SNP locations
must have allele data present for both strains, 26,831 SNP lo-
cation rows were retrieved. Selecting the entire genome, and
requiring that there must be polymorphism between BALB/
cByJ and BALB/cJ for a SNP location to be displayed, 41 SNP
location rows were retrieved, reflecting an average 0.15% dif-
ference. A similar comparison for BALB/cByJ and C57BL/
6ByJ yielded 33.28% difference. For Grm7 no SNPs could be
retrieved in a BALB/cByJ vs BALB/cJ comparison. These
suggest that the genomic difference between BALB/cByJ and
BALB/cJ and the risk of obtaining false information due to the
strain substitution are relatively small.
Taken together, the reviewed evidence establishes a sig-
nificant functional relevance of mGluR7 in psychostimulant-
related behaviors, including oral alcohol self-administration.
A potential source of error is introduced in the analysis by
the method used to filter candidate genes residing in the donor
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our use of the IBD concept does not assume that the genomes of
inbred strains follow a simple block-like structure, which could
be used conveniently in QTL mapping [84], and we use this
concept strictly in a bilineal comparison relying on a defined
SNP frequency threshold (b20/100 kb), visual inspection of
each 100-kb bin, and having access to high-quality genome
sequence of the strains recently made available by the NIEHS
DNA resequencing efforts, still, there is a chance that relevant
genes escaped detection. Another potential source of error is to
focus on cis-regulated genes exclusively. Gene expression is a
phenotype subject to numerous developmental and environ-
mental effects. Lack of attention to its spatiotemporal limita-
tions may lead to erroneous conclusions.
To counteract these potential effects on the validity of gene
identification, we searched the donor segment for structural
polymorphism and identified 10 genes with CNs. These genes
cannot be excluded as potential candidates but their known
functions do not suggest any obvious plausible links to alco-
hol drinking preference or addiction. Moreover, allelic asso-
ciation with alcohol consumption was shown in an additional,
alternative genetic design using segregating near-isogenic
animals. Importantly, in this design the position of the target-
ed donor segment excluded contribution from both cis-regu-
lated and structurally polymorph candidate genes residing in
proximal regions of chromosome 6. Finally, we presented a
large body of evidence in support of the functional rele-
vance of Grm7 (mGluR7) to psychostimulant/alcohol-related
behaviors.
In summary, using near-isogenic advanced animal models
with reduced genetic background interactions, gene mapping
and gene mRNA expression data in segregating and congenic
mice were integrated in a search for a gene underlying Eac2, a
QTL for alcohol consumption. We identified glutamate receptor
metabotropic 7 (Grm7) as a cis-regulated gene for alcohol con-
sumption. Confirmation of its role requires further rigorous
work including fine mapping and mechanistic studies, which
are in progress in our laboratory. It is likely that the predisposing
effects of Grm7 polymorphism are not restricted to alcohol-
related behaviors; it may play a modulatory role in other forms
of addiction and comorbid psychiatric disorders.Materials and methods
Animals
Progenitors of B6By, CXBI/ByJ (I), and C inbred mouse strains were
obtained from The Jackson Laboratory (Bar Harbor, ME, USA). The quasi-
congenic RQI strains and the chromosome 6 congenic B6By.C6 mice were
developed in our research colony at The Nathan Kline Institute for Psychiatric
Research, Office of Mental Health, New York State (NKI) as described [6]. All
other mice were bred and maintained in our colony. Animals were housed in
groups (three to five per cage) under standard laboratory conditions (12 h light/
12 h dark cycle) with food and water available ad libitum. At the time of
testing, animals were housed individually with lab chow and water conti-
nuously available. All reported data refer to male mice. The care and use of
animals met the standards and recommendations of the IACUC of NKI in
accordance with U.S. Department of Agriculture and U.S. Public Health
Service guidelines.Development of congenic strain B6By.C6
The alcohol-nonpreferring quasi-congenic RQI strain B6.Cb5i7-Alpha3
(C5A3) was developed by five backcross–intercross cycles using the alcohol-
avoiding C strain as donor and the alcohol-preferring B6By strain as background
[6,28]. Using C5A3 as a progenitor, the congenic B6.C6 strain was developed
by an additional five backcrosses to B6By with concomitant selection for C
alleles of Chr. 6 microsatellite markers (e.g., D6Mit105). Other relevant markers
were selected from the genome-wide genotype database of RQI strains (http://
rqigenetics.org/). Congenic status was tested by a genome scan with a mouse
SNP panel of 402 markers (service provided by Genetics Division, Brigham and
Women’s Hospital, Harvard Medical School). Only the expected single Chr. 6
donor segment was detected as of C origin (Fig. S1).
Oral alcohol self-administration
In all experiments a “two-bottle” choice paradigm with escalating alcohol
concentration was used. Male mice were individually housed in our drinking
study room for at least 1 week prior to beginning the study. Mice were tested for
alcohol preference and consumption according to the procedure for oral self-
administration as described [6,85]. Two versions of the “two-bottle” choice
paradigm were used, one with contiguous trials, and one with intermittent trials.
(1) “Two-bottle” choice paradigm with contiguous trials. The test consisted of
six 3-day trials, in which mice were allowed to choose between alcohol solution
and tap water. To acclimate the animals to the taste of alcohol, the alcohol
solution was offered in escalating concentrations: a 3% solution for trial 1 (days
1–3) was increased to 6% in trial 2 (days 3–6), and further increased to 12% for
trials 3 (days 6–9), 4 (days 9–12), 5 (days 12–15), and 6 (days 15–18). This
arrangement provided multiple measures of alcohol preference at 12%
concentration (v/v). Because offering alcohol solutions of 3 and 6% served
the primary purpose of acclimation of animals to 12% solution, we did not carry
out experiments in duplicate for 3 and 6% alcohol consumption, and we did not
use these data for analysis. (2) “Two-bottle” choice paradigm with intermittent
trials. The test consisted of eight 3-day trials, in which mice were allowed to
choose between alcohol solution and tap water. As above, the alcohol solution
was offered in escalating concentrations: a 3% solution for trial 1 and trial 2 was
increased to 6% in trial 3 and trial 4 and further increased to 12% for trials 5–8.
After every two trials, mice had access to water only for 24 h (from Monday
morning through Tuesday morning). Thus, the total experiment with intermittent
access lasted for 4 weeks. For analysis only trials 5–8 were used.
The liquids were offered in custom-made drinking tubes composed of
centrifuge tubes fitted with single-hole rubber stoppers into which stainless steel
sippers were inserted. We also used stainless-steel springs to fasten the tubes
firmly to the top of the cage covers. Two empty cages with alcohol and tap water
drinking tubes were put on the racks to obtain control weights for leakage and
evaporation. For each trial, the mean control values were subtracted from the
alcohol and water consumption data. Food was located on the cover at the front
of the cage, with one drinking tube always nearer to the food than the other. The
positions of the water and alcohol drinking tubes on the cage cover were
alternated in each 3-day preference trial to avoid a position effect. The weights
of the drinking tubes were measured before and after a 3-day trial using an A&D
electronic analytical balance connected to a computer. Data were entered auto-
matically using A&D software and spreadsheets. After correction for dripping
and evaporation, data from the four 3-day trials were averaged for each
individual.
Brain dissection, RNA labeling, and microarray processing
We used adult, male B6By, B6By.C6, and C mice (n=30; 90 mice in toto).
Animals were killed by cervical dislocation, brains were quickly removed and
hemisectioned. and alternate left or right hemispheres were collected in RNA-
Later for expression studies. After each hemisphere was processed separately, 10
hemispheres were pooled for one high-density oligonucleotide microarray
(Mouse Genome 430 2.0; Affymetrix, Santa Clara, CA, USA). For each strain
three oligonucleotide microarrays were used (n=3). RNA was isolated using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and RNeasy Mini Kits
(Qiagen, Valencia, CA, USA). The yield of total RNA from each tissue sample
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RNA according to the protocol of Affymetrix using Superscript Choice System
(Invitrogen) and an RNA Transcript Labeling Kit (Enzo, Farmingdale, NY,
USA). cRNA quality analysis on a 2100 Bioanalyzer, hybridization to
GeneChips, and scanning of the arrays were carried out in accordance with the
manufacturer’s protocol at the Genomics Facility of the New York University
Cancer Institute using Gene Chip Operating Software (GCOS).
Microarray gene expression data acquisition and normalization
Raw data with MIAME-compliant annotations of experiments were
uploaded to Gene Traffic Database (http://genetraffic.med.nyu.edu/; Iobion
Informatics, LLC). We used .CEL files produced by GCOS for probe (cell)-level
RMA-based normalization of data [86]. All subsequent analyses were done on
RMA-normalized data. Data from these studies are available at Gene Expression
Omnibus (GEO series entry GSE7155). All public gene expression data were
based on Affymetrix Mouse Gene Expression Array 430 2.0. CXB RI hippo-
campal, BXD hippocampal, BXD striatal, and B6D2F2 striatal mRNA data were
obtained from the Hippocampus Consortium M430v2 CXB (Dec05) RMA
database, Hippocampus Consortium M430v2 BXD (Dec05) PDNN database,
HBP/Rosen Striatum M430V2 (Apr05) MAS5 Clean database, and OHSU/VA
B6D2F2 Striatum M430v2 (Sep05) PDNN database, respectively, at http://
www.genenetwork.org/public/WebQTL.
Bioinformatic analysis
Ongoing resequencing efforts made available large SNP genotype data sets
for numerous inbred strains, including B6 and CBy, closely related sublines of
our progenitor strains B6By and C (http://www.jax.org/phenome/snp.html).
Because currently our progenitor strains B6By and C are not as well
characterized in bioinformatic databases as the closely related sublines B6 and
CBy, in the present analysis we took advantage of the excellent bioinformatic
coverage and Mouse Phenome Database priority strain status of B6 and CBy. In
a comparison of C and CBy for all SNPs on Chr. 6 we found 3063 SNPs, while
the number of different SNPs was 188. This suggests 188/3063=6.14% SNP
differences on Chr. 6, the length of which is 149.4 Mb. Assuming even
distribution, a rough estimate of the average density of subline SNPs is 188/
149.4=1.258, i.e., subline SNP density b2 SNP/Mb (http://www.informatics.
jax.org/javawi2/servlet/WIFetch?page=snpQF). This is well below the threshold
applied for detection of IBD regions (20 SNPs/0.1 Mb) by us and others. In SNP
database searches B6 and CBy were substituted for B6By and C if database
information was limited for the progenitor strains. Promoter analysis of Grm7
was carried out with the PromoterInspector program (http://www.genomatix.de;
Eldorado 08-2006 database, NCBI build 36, extracted region: NC_000072
between 110,571,933 and 111,571,932). Positions for the 218 SNPs in Grm7
(detected between B6 and CBy or C) were obtained at http://www.informatics.
jax.org/; NCBI build 36, 110,611,375–111,533,007. TFBSs were analyzed by
MatInspector, the leading program for promoter analysis [87]. The promoter
analysis focused on a 41-bp region, which included the SNP rs30557150
Y=C/T (Fig. 3).
Segregating F2 population studies
RQI quasi-congenic strains with significant differences in alcohol
consumption have been described [6,7]. Reciprocal F2 populations were created
by using alcohol-preferring (I5B25A) and alcohol-nonpreferring (C5B3) quasi-
congenic progenitor strains. Both strains carry N97% B6 genome. The sample
sizes of the (C5B3×I5B25A)F2 and (I5B25A×C5B3)F2 male mice were 159
and 163, respectively. Phenotypic “extremes” were identified as 1 SD below or
above the mean alcohol consumption value and were subjected to selective
genotyping. The selectively genotyped sample sizes were n=28 for (C5B3×
I5B25A)F2 and n=30 for (I5B25A×C5B3)F2. To test the association of allelic
variants of Grm7 with alcohol consumption, the phenotypically selected F2
mice were genotyped for SNP rs3723352, which resides in intron7 of Grm7 at
111.513Mb (NCBI build 36). For allelic variation of rs3723352 in inbred strains
we searched the Mouse Phenome Database (http://phenome.jax.org/pubcgi/
phenome/mpdcgi?rtn=snps%2Fretrieve&searchreq=rs3723352).Multistrain correlation between alcohol consumption and SNP
genotype
Genotypes for Nfu1 (rs30605208), Aak1 (rs30912462), Grm7 (rs305571
150), and Chchd4 (rs30014728) were obtained at http://www.informatics.jax.
org/. For the correlation analysis SNP genotypes with the C57BL/6J-type allele
were assigned “0”, while the other allele was assigned “1” (genotypes for some
strains were not available). All published alcohol consumption data (g/kg/day)
were used without adjustment [21–23].
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